Stories by Issue
Posts Tagged as "COVID-19 vaccine"
Pfizer requests FDA authorization for updated COVID-19 booster shots that target the BA.4 and BA.5 variants
Pfizer recently asked the Food and Drug Administration (FDA) to authorize their newly updated COVID-19 booster shots for people aged 12 and older.
What we know about Omicron and the BA.5 variant
Accounting for 65 percent of last week’s COVID-19 cases, the coronavirus subvariant BA.5 — a sister variant of Omicron — has become dominant in the United States.
FDA authorizes Pfizer boosters for children ages five to 11
Children who have received two doses of the vaccine are now eligible to receive their COVID-19 booster at least five months after their second shot; as of now, this is the only vaccine available to children ages five to 11.